Patents by Inventor Daniel Otts

Daniel Otts has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240080207
    Abstract: The disclosure provides an approach for certificate management for cryptographic agility. Embodiments include receiving, by a cryptographic agility system, a cryptographic request related to an application. Embodiments include selecting, by the cryptographic agility system, a cryptographic technique based on contextual information associated with the cryptographic request. Embodiments include determining, by the cryptographic agility system, based on the cryptographic request, a certificate for authenticating a key related to the cryptographic technique. Embodiments include providing, by the cryptographic agility system, the certificate to an endpoint related to the cryptographic request for use in authenticating the key.
    Type: Application
    Filed: July 27, 2023
    Publication date: March 7, 2024
    Inventors: Marc Wayne BROTHERSON, Mark BENSON, Daniel James BEVERIDGE, Sean HUNTLEY, Akeem JENKINS, David OTT
  • Patent number: 11924343
    Abstract: The disclosure provides an approach for cryptographic agility. Embodiments include establishing, by a proxy component associated with a cryptographic agility system, a first secure connection with an application. Embodiments include receiving, by the proxy component, via the first secure connection, a communication from the application directed to an endpoint. Embodiments include selecting, by the cryptographic agility system, a cryptographic technique based on contextual information related to the communication. Embodiments include establishing, by the proxy component, a second secure connection with the endpoint based on the cryptographic technique. Embodiments include transmitting, by the proxy component, a secure communication to the endpoint via the second secure connection based on the communication.
    Type: Grant
    Filed: July 26, 2021
    Date of Patent: March 5, 2024
    Assignee: VMware, Inc.
    Inventors: Akeem Jenkins, Mark Benson, Daniel James Beveridge, Marc Wayne Brotherson, Sean Huntley, David Ott
  • Publication number: 20240036325
    Abstract: A display may include an optical emitter that emits infrared light, a first coupler that couples the infrared light into a waveguide, and a second optical coupler that couples the infrared light out of the waveguide and towards the eye box. The infrared light may reflect off an eye as reflected light. The second optical coupler may couple the reflected light into the waveguide and the first optical coupler may couple the reflected light out of the waveguide and towards a camera for performing gaze tracking operations based on the sensor data. The display may sequentially illuminate different regions of the eye with the infrared light at different times using a scanning mirror, an array of light sources, or a wavelength-adjustable light source and gratings. This may minimize infrared light scattering, which minimizes background generation and maximizes signal-to-noise ratio for gaze tracking operations.
    Type: Application
    Filed: July 10, 2023
    Publication date: February 1, 2024
    Inventors: Itai Afek, Ariel Lipson, Eran Tal, Mark R. Ayres, Ken Anderson, Maria I. Campana, Daniel Ott, Roei Remez, Sagee Rosen
  • Patent number: 11866531
    Abstract: Lens materials and ophthalmic devices including lens materials that are oxygen permeable and resistant to oil absorption are described. In an embodiment, the lens material includes a copolymer composed of repeating units including: a fluorinated acrylate repeating unit; and a silicon-containing repeating unit, wherein a mass:mass ratio of the fluorinated acrylate repeating unit to the silicon-containing repeating unit is greater than or equal to 2:1.
    Type: Grant
    Filed: September 24, 2020
    Date of Patent: January 9, 2024
    Assignee: Twenty Twenty Therapeutrics LLC
    Inventors: Angela DiCiccio, Daniel Otts, Stein Kuiper
  • Patent number: 11858021
    Abstract: A control device (3b) for a roll stand (1). During rolling of a metal strip (2) in the roll stand (1), the device receives measurement data (M) for a lateral position (y) of the metal strip (2) on the inlet side and/or outlet side of the roll stand (1). Taking into account parameters (P) of the stand regulator (3a) on the basis of the deviation in the lateral position (y) from a target position (y*), a stand regulator (3a) of the control device (3b) determines a tilt value (?s) for the roll stand (1) and controls the roll stand (1) accordingly. The control device (3b) determines at least one variable (V1, V2, Q1, Q2) from which it is derived, for both strip edges (7, 8) of the metal strip (2), whether the metal strip (2) forms an undulation (9) in the region of the particular strip edge (7, 8).
    Type: Grant
    Filed: March 5, 2020
    Date of Patent: January 2, 2024
    Inventors: Martin Kerschensteiner, Daniel Kotzian, Matthias Kurz, Klaus Loehe, Andreas Maierhofer, Daniel Ott, Mirko Tunk
  • Patent number: 11703697
    Abstract: A contact lens includes a posterior element, an anterior element, and a first fluid. The posterior element is adapted to conform to a surface of an eye when the contact lens is mounted on the eye. The anterior element is coupled to the posterior element to form a cavity within the contact lens. A flexibility of the posterior element is greater than a flexibility of the anterior element. The first fluid is disposed within the cavity and a distribution of the first fluid within the cavity changes in response to the posterior element conforming to the eye when the contact lens is mounted on the eye.
    Type: Grant
    Filed: December 19, 2019
    Date of Patent: July 18, 2023
    Assignee: Verily Life Sciences LLC
    Inventors: Stein Kuiper, Daniel Otts
  • Publication number: 20220250128
    Abstract: A control device (3b) for a roll stand (1). During rolling of a metal strip (2) in the roll stand (1), the device receives measurement data (M) for a lateral position (y) of the metal strip (2) on the inlet side and/or outlet side of the roll stand (1). Taking into account parameters (P) of the stand regulator (3a) on the basis of the deviation in the lateral position (y) from a target position (y*), a stand regulator (3a) of the control device (3b) determines a tilt value (?s) for the roll stand (1) and controls the roll stand (1) accordingly. The control device (3b) determines at least one variable (V1, V2, Q1, Q2) from which it is derived, for both strip edges (7, 8) of the metal strip (2), whether the metal strip (2) forms an undulation (9) in the region of the particular strip edge (7, 8).
    Type: Application
    Filed: March 5, 2020
    Publication date: August 11, 2022
    Inventors: Martin KERSCHENSTEINER, Daniel KOTZIAN, Matthias KURZ, Klaus LOEHE, Andreas MAIERHOFER, Daniel OTT, Mirko TUNK
  • Patent number: 11258132
    Abstract: In one example, a battery includes a negative terminal, a positive terminal, an electrolyte contained between the negative terminal and the positive terminal, and a hydrogel layer positioned between and physically separating the negative terminal and the positive terminal.
    Type: Grant
    Filed: August 14, 2019
    Date of Patent: February 22, 2022
    Assignees: INTERNATIONAL BUSINESS MACHINES CORPORATION, JOHNSON & JOHNSON VISION CARE, INC.
    Inventors: Paul S. Andry, Eric Lewandowski, Adam Toner, Daniel Otts, James Daniel Riall, Cornelia T. Yang
  • Patent number: 11197752
    Abstract: An eye-implantable electrowetting lens can be operated to control an overall optical power of an eye in which the device is implanted. A lens chamber of the electrowetting lens contains first and second fluids that are immiscible with each other and have different refractive indexes. By applying a voltage to electrodes of the lens, the optical power of the lens can be controlled by affecting the geometry of the interface between the fluids. When the electrowetting lens is inserted into the eye, the lens chamber may contain only one of the first and second fluids. The other fluid can be added after insertion through a needle, a tube, or some other means. Having only one of the first and second fluids in the lens chamber during insertion of the lens can prevent fouling of internal surfaces due to folding or other manipulation of the lens during the insertion process.
    Type: Grant
    Filed: April 5, 2018
    Date of Patent: December 14, 2021
    Assignee: Verily Life Sciences LLC
    Inventors: Daniel Otts, Stein Kuiper
  • Patent number: 11191636
    Abstract: An eye-implantable electrowetting lens can be operated to control an overall optical power of an eye in which the device is implanted. A lens chamber of the electrowetting lens contains first and second fluids that are immiscible with each other and have different refractive indexes. By applying a voltage to electrodes of the lens, the optical power of the lens can be controlled by affecting the geometry of the interface between the fluids. To prevent fouling the surface due to folding or other manipulation of the lens during the insertion process, one or more surfaces within the lens chamber is highly underwater oleophobic.
    Type: Grant
    Filed: August 21, 2018
    Date of Patent: December 7, 2021
    Assignee: Verily Life Sciences LLC
    Inventors: Stein Kuiper, Daniel Otts
  • Publication number: 20210170390
    Abstract: An in-vitro diagnostic device including a pipetting unit and a pipetting method, which allow for a more reproducible and more precise pipetting of liquids, when piercing through a lid of a closed liquid container is required. The pipetting unit is controlled to repeat penetration of the lid of the closed liquid container if the pressure difference between the interior of the liquid container and the surrounding is outside an allowable predefined pressure range.
    Type: Application
    Filed: November 17, 2020
    Publication date: June 10, 2021
    Applicant: Roche Diagnostics Operations, Inc.
    Inventors: Ronald Egli, Mirko Klingauf, Daniel Ott, Jerome Wiss
  • Publication number: 20210121287
    Abstract: A flexible intraocular lens including a reinforcing layer disposed on a sidewall of the intraocular lens is described. An example flexible intraocular lens includes a lens body and a reinforcing layer disposed thereon.
    Type: Application
    Filed: December 28, 2020
    Publication date: April 29, 2021
    Inventors: Stein Kuiper, Daniel Otts
  • Publication number: 20210095063
    Abstract: Lens materials and ophthalmic devices including lens materials that are oxygen permeable and resistant to oil absorption are described.
    Type: Application
    Filed: September 24, 2020
    Publication date: April 1, 2021
    Inventors: Angela DiCiccio, Daniel Otts, Stein Kuiper
  • Publication number: 20210096400
    Abstract: Systems and kits for replenishing an electrowetting ophthalmic device are described. In an embodiment, the system includes an electrowetting ophthalmic device including a lens material defining a cavity encasing an aqueous electrowetting solution; a replenishing solution having an osmolarity approximately equal to an osmolarity of the aqueous electrowetting solution; and a container shaped to carry the electrowetting ophthalmic device and the replenishing solution and to position the electrowetting ophthalmic device in contact with the replenishing solution when the electrowetting ophthalmic device and the replenishing solution are carried by the container. In an embodiment, the osmolarity of the aqueous electrowetting solution is higher than an osmolarity of a tear fluid of an eye.
    Type: Application
    Filed: September 24, 2020
    Publication date: April 1, 2021
    Inventors: Daniel Otts, Stein Kuiper
  • Patent number: 10918476
    Abstract: An eye-implantable device including an electrowetting lens is provided that can be operated to control an overall optical power of an eye in which the device is implanted. A lens chamber of the electrowetting lens contains first and second fluids that are immiscible with each other and that differ with respect to refractive index. By applying a voltage to electrodes of the lens, the optical power of the lens can be controlled by affecting the geometry of the interface between the fluids. One of the fluids is an aqueous fluid that is isotonic relative to the aqueous humor of the eye to prevent flux of water into or out of the lens chamber. Thus, the lens chamber may be composed of water-permeable materials. Such water-permeable materials may be flexible, to permit the lens to be folded into a smaller profile during implantation.
    Type: Grant
    Filed: January 12, 2018
    Date of Patent: February 16, 2021
    Assignee: Verily Life Sciences LLC
    Inventor: Daniel Otts
  • Patent number: 10874506
    Abstract: A flexible intraocular lens including a reinforcing layer disposed on a sidewall of the intraocular lens is described. An example flexible intraocular lens includes a lens body and a reinforcing layer disposed thereon.
    Type: Grant
    Filed: January 28, 2019
    Date of Patent: December 29, 2020
    Assignee: VERILY LIFE SCIENCES LLC
    Inventors: Stein Kuiper, Daniel Otts
  • Patent number: 10869753
    Abstract: An eye-implantable device including an electrowetting lens is provided that can be operated to control an overall optical power of an eye in which the device is implanted. A lens chamber of the electrowetting lens contains first and second fluids that are immiscible with each other and that differ with respect to refractive index. By applying a voltage to electrodes of the lens, the optical power of the lens can be controlled by affecting the geometry of the interface between the fluids. One or both of the fluids can have a melting point slightly below body temperature. Freezing such an oil or other fluid of the lens can prevent fouling of internal surfaces of the lens due to folding or other manipulation of the lens during implantation. Once implanted, the fluids are melted by body heat such that the optical power of the lens may be controlled.
    Type: Grant
    Filed: April 5, 2018
    Date of Patent: December 22, 2020
    Assignee: Verily Life Sciences LLC
    Inventors: Daniel Otts, Stein Kuiper
  • Patent number: 10866431
    Abstract: A device is provided that may be operated when implanted within a body, when mounted to a surface of an eye, or when immersed in a fluid or otherwise exposed to a humid environment. The device includes at least one conductor that includes a valve metal. The valve metal is disposed on an external surface of the conductor such that, when the conductor exhibits a positive voltage relative to its environment, the valve metal forms or maintains a self-limiting oxide layer. The device is operated such that the mean voltage of the conductor is positive or zero relative to the environment, e.g., relative to another electrode or other conductor of the device that is in contact with fluid in the environment. Such a device can be operated for a protracted period of time in a humid environment without a hermetic seal disposed between the conductor and the humid environment.
    Type: Grant
    Filed: September 7, 2018
    Date of Patent: December 15, 2020
    Assignee: Verily Life Sciences LLC
    Inventors: Stein Kuiper, Daniel Otts
  • Patent number: 10850002
    Abstract: An eye-mountable device includes a hydrogel material. By drying the hydrogel material of the eye-mountable device, ethylene oxide may be used to sterilize the eye-mountable device. Such a sterilization method can be employed to sterilize the eye-mountable device when the eye-mountable device includes electronics, sensors, actuated lenses, or other components that may be damaged by heat, pressure, radiation, or other conditions used for sterilization. The eye-mountable device may be stored, dry, within a sealed sterile volume of a packaging material. The packaging material may be permeable to ethylene oxide such that the dried eye-mountable device may be sterilized by ethylene oxide after being sealed within the packaging material. The eye-mountable device could take the form of a contact lens, the form of a device configured to be placed against a sclera of an eye beneath an eyelid of the eye, or could take some other form.
    Type: Grant
    Filed: September 7, 2017
    Date of Patent: December 1, 2020
    Assignee: Verily Life Sciences LLC
    Inventor: Daniel Otts
  • Publication number: 20200330747
    Abstract: Biomaterials, such as hydrogels, can be mechanically secured to an electrode of an implantable device using a non-swellable shell. Hydrogel can be applied to an electrode surface and then mechanically constrained in place by a non-swellable shell. The non-swellable material can be secured to a substrate supporting an electrode or can otherwise surround an electrode and the hydrogel. The non-swellable shell can include openings or passthroughs that allow for electrical conduction across the non-swellable shell. The hydrogel can extend out of the openings to contact adjacent biological tissue. In some cases, an outer layer of hydrogel can surround the non-swellable shell and connected to the inner layer of hydrogel through the openings of the non-swellable shell.
    Type: Application
    Filed: July 1, 2020
    Publication date: October 22, 2020
    Applicant: Verily Life Sciences LLC
    Inventors: Huanfen Yao, Kimberly Kam, Daniel Otts